Home
|
Job-opportunities
|
Contact
|
News
|
Donate
Overview
DNDi Worldwide
Business Model
Stakeholders
Friends of DNDi
Our People
Annual Report
DNDi's Policies
Endorsements
Letter from Chairman and Executive Director
Diseases
Portfolio
R&D Organisation
Building Portfolio
Clinical Trial Protocols
Open Innovation
ASAQ
ASMQ
NECT
SSG&PM
Paediatric Benznidazole
LEAP Platform
HAT Platform
Chagas Platform
Technology transfer ASMQ
Technology transfer ASAQ
Global
Access
IP
Regulatory
Sustainable Funding
Press Kit
Press Releases
Press Articles
Scientific Publications
Newsletters
Outlooks
Multimedia
Events
Press Room
Business Model
Partners
IP & Licensing Policies
To Become a DNDi Partner
How to help
Donors
Key Financial Figures
Fundraising Policy
Donate
Home
Annual Report
Overview
DNDi Worldwide
Business Model
Stakeholders
Friends of DNDi
Our People
Annual Report
DNDi's Policies
Endorsements
Letter from Chairman and Executive Director
Annual Report
Annual Report 2010
Financial & Performance Report 2009
Annual Report 2008-2009
Annual Report 2007-2008
Annual Report 2006
Page 1 of 6
Through its annual reports, DND
i
publishes the main achievements of its R&D projects
and activities, and provides comprehensive information about the organization’s
performance and latest accomplishments in the field of neglected diseases.
DND
i
's ANNUAL REPORT 2010
1.
Overview & Governance
[PDF 8MB]
2.
R&D Model, Strategy & Portfolio
[PDF 1.1MB]
3.
Strenghtening existing capacities
[PDF 260KB]
4.
Advocacy, communication & fundraising
[PDF 638KB]
5.
Financial & performance report
[PDF 606KB]
Download full
Annual report 2010
[PDF 10.2MB]
SITEMAP
DISCLAIMER
PRIVACY
Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License